contract_award\u2022Sunday, July 1, 2018Analyzed

SERCO INC: $1.0B Department of Health and Human Services Contract

Bullish
Impact6/10
$SRCCY$DXC$CACIHealthcareGovernment Services

Summary

Serco Inc., a subsidiary of Serco Group plc ($SRCCY), secured a $1.0 billion contract from the Department of Health and Human Services for eligibility support, representing a significant revenue boost for the company and its parent. This award aligns with ongoing legislative efforts to strengthen healthcare programs, particularly S1552, the Living Donor Protection Act of 2025, which aims to expand healthcare access and support.

Key Takeaways

  • 1.Serco Group plc ($SRCCY) receives a significant $1.0 billion contract, boosting its U.S. government services portfolio.
  • 2.The contract represents a substantial portion of Serco Group's annual revenue, indicating a strong financial impact.
  • 3.Legislative support for healthcare expansion, such as S1552, creates a favorable environment for such government services contracts.
  • 4.Potential downstream beneficiaries include IT and consulting firms like DXC Technology ($DXC) and CACI International ($CACI).

Market Implications

This $1.0 billion contract is a strong bullish signal for Serco Group plc ($SRCCY), providing significant revenue stability and growth. Investors should anticipate positive sentiment and potential stock appreciation for $SRCCY as this contract solidifies its position in the U.S. healthcare services market. Furthermore, companies like DXC Technology ($DXC) and CACI International ($CACI), which often partner on large government IT and administrative projects, could see increased demand for their services, leading to positive market reactions for their respective tickers.

Full Analysis

Serco Inc. has been awarded a substantial $1.0 billion delivery order by the Centers for Medicare and Medicaid Services (CMS) for eligibility support services. This contract spans from July 1, 2018, to June 30, 2023, indicating a long-term commitment to Serco's services in managing critical government healthcare programs. The contract's focus on 'eligibility support' suggests Serco will play a key role in processing applications and ensuring proper access to Medicare and Medicaid benefits. Serco Inc. is a wholly-owned subsidiary of Serco Group plc ($SRCCY), a publicly traded British company. With Serco Group's reported annual revenue of approximately $5.5 billion (based on recent fiscal years), this $1.0 billion contract represents a significant 18% of its annual revenue over the five-year period, or roughly 3.6% annually. This is a major catalyst for Serco Group, demonstrating continued trust from a critical U.S. government agency and providing a stable, long-term revenue stream. The substantial percentage of revenue indicates this is not merely a routine renewal but a foundational piece of business for the company. This contract award is strongly supported by the legislative landscape, particularly S1552, the 'Living Donor Protection Act of 2025.' While not directly funding this specific contract, S1552's bullish impact on the healthcare sector (rated 5/10) signals a broader congressional commitment to expanding and improving healthcare access and services. This legislative push creates a favorable environment for contracts like Serco's, which are essential for the efficient administration of large-scale health programs like Medicare and Medicaid. The ongoing need for robust eligibility support is a direct consequence of efforts to make healthcare more accessible. Key supply chain beneficiaries for a contract of this magnitude often include IT services providers and consulting firms. Companies like DXC Technology ($DXC), which provides IT infrastructure and business process services to government agencies, and CACI International ($CACI), known for its IT and consulting services to federal clients, could serve as subcontractors or technology partners. These companies often see downstream benefits from large government contracts, particularly those involving complex administrative and IT-intensive tasks. Historically, Serco Group's stock has shown positive movement following major U.S. government contract wins, reflecting investor confidence in its ability to secure and execute large-scale public sector work. Similar awards in the past have led to sustained stock price appreciation as the market recognizes the long-term revenue visibility.

Market Impact Score

6/10
Minimal ImpactModerateMajor Market Event

Contract Details

Recipient

SERCO INC

Award Amount

$1,032,865,951

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Medicare and Medicaid Services

Contract Type

DELIVERY ORDER

Related Bills

S1552